G Sheean - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G Sheean

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Seizure|December 1, 1996

A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizuresR G Beran, S F Berkovic, N Buchanan, et al.

Muscle & Nerve|June 19, 2001

Nerve conduction changes in patients with mitochondrial diseases treated with dichloroacetateL Spruijt, R K Naviaux, K A McGowan, et al.

Journal of American College Health : J of ACH|June 7, 2024

Anchor universities as leaders in the well-being movement: lessons learned from the University of California Healthy Campus Network & pandemicWendelin Slusser, L Schmidt, C Imbery, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Seizure|December 1, 1996

A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizuresR G Beran, S F Berkovic, N Buchanan, et al.

Muscle & Nerve|June 19, 2001

Nerve conduction changes in patients with mitochondrial diseases treated with dichloroacetateL Spruijt, R K Naviaux, K A McGowan, et al.

Journal of American College Health : J of ACH|June 7, 2024

Anchor universities as leaders in the well-being movement: lessons learned from the University of California Healthy Campus Network & pandemicWendelin Slusser, L Schmidt, C Imbery, et al.

Pageof 2